CASI

CASI Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for cancer and other serious diseases. Based in Rockville, Maryland, CASI is strategically positioned to tap into both the expansive Chinese market and global healthcare opportunities, utilizing its advanced research capabilities to address significant unmet medical needs. With a diverse and promising pipeline of targeted therapies, the company aims to leverage the growing demand for novel treatment options in an increasingly dynamic market, making it an attractive prospect for institutional investors seeking exposure in the biopharmaceutical sector.